Rare diseases
Investigational molecules
Locations
Edvarda Benese 1128/13, Jizni Predmesti, 301 00 Plzen, Czechia
Fakultni Nemocnice Plzen in Plzen, Czechia specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, B-cell small lymphocytic lymphoma, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in hematologic malignancies, focusing on innovative treatments for conditions such as Primary Myelofibrosis, Chronic Myeloid Leukemia, and Multiple Myeloma. The center's work in this area aims to improve patient outcomes through advanced therapeutic strategies.
By integrating cutting-edge research with clinical practice, the center is enhancing the understanding and treatment of these complex diseases.
Specializing in oncology, the center conducts pivotal studies on various cancers, including Renal Cell Carcinoma and Non-small Cell Lung Cancer. These studies are crucial for developing new treatment protocols and improving survival rates.
The center's commitment to oncology research is evident in its comprehensive approach to understanding cancer biology and treatment.
In the realm of cardiovascular diseases, the center is pioneering research on Chronic Heart Failure and Atherosclerotic Cardiovascular Disease. These efforts are directed towards developing novel therapies that address the underlying mechanisms of these conditions.
Through its research, the center is contributing to the advancement of cardiovascular medicine, offering hope for improved patient care.
The center's dermatology research focuses on Moderate to Severe Plaque Psoriasis and Hidradenitis Suppurativa. By exploring new treatment modalities, the center aims to enhance the quality of life for patients with these chronic skin conditions.
Innovative research in dermatology is paving the way for more effective and personalized treatment options.
In gastroenterology, the center is advancing the understanding of Short Bowel Syndrome and Cirrhosis. Research efforts are focused on improving long-term outcomes and quality of life for patients with these challenging conditions.
The center's work in this field is instrumental in developing new therapeutic approaches and enhancing patient care.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
CzechiaStudy on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease
CzechiaStudy on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
CzechiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
CzechiaA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
CzechiaEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
CzechiaPhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
CzechiaLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
CzechiaPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
CzechiaA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
CzechiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
